{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/glaucoma/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"744db240-54ad-5b2b-bde1-fbf5f82dd75c","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field a9716693-b4d3-401a-a1a4-7051ba8a4ac5 --><h2>Update</h2><!-- end field a9716693-b4d3-401a-a1a4-7051ba8a4ac5 -->","summary":null,"htmlStringContent":"<!-- begin item 4635512a-063b-48d6-b8a3-cb976fa912cd --><!-- end item 4635512a-063b-48d6-b8a3-cb976fa912cd -->","topic":{"id":"2f2ce020-977b-56c2-bfe0-79af338099b2","topicId":"3f1d1b43-0970-4917-b518-15a04dfd4397","topicName":"Glaucoma","slug":"glaucoma","lastRevised":"Last revised in November 2020","chapters":[{"id":"b70753e1-40bf-5d64-8042-80499a3a3663","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"99932988-c7ac-5201-8a03-324771c52186","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"4665a282-8076-541c-8fdb-d884f514e73a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"90547efd-385b-5418-95dc-840a239bb4b6","slug":"changes","fullItemName":"Changes"},{"id":"744db240-54ad-5b2b-bde1-fbf5f82dd75c","slug":"update","fullItemName":"Update"}]},{"id":"1b9b2a0b-c1eb-5850-81a4-594deb443996","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d96d012a-8a50-5197-a3bc-80be922d4ec3","slug":"goals","fullItemName":"Goals"},{"id":"ab168d63-48cb-5e39-af87-b20be5416a2b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1371aed7-3648-50af-9b62-765d61209340","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e5d9b1dc-20e2-5c90-807b-c86643d03e27","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"634d007b-489f-5899-be8c-e79e2c12d416","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"895cf400-6256-5dd3-9e84-20a916980e46","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"05123836-33c6-55ab-87b4-82c858ac280b","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"e281b4eb-d1e1-5e3a-ac1e-ba1ce5a60a71","slug":"definition","fullItemName":"Definition"},{"id":"1d1f8e60-4614-5dcc-a66d-9019ca4e6e03","slug":"anatomy-physiology","fullItemName":"Anatomy and physiology"},{"id":"00e7c765-c989-527f-b21f-29ad09409af8","slug":"classification","fullItemName":"Classification"},{"id":"855a9d74-8bb6-54d9-bfc9-5c385ae0f3f4","slug":"causes","fullItemName":"Causes"},{"id":"89456b4f-1b83-5bd6-ba80-018c1171090d","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"37e8081e-c003-5262-a267-bf22817b2d3d","slug":"prevalence","fullItemName":"Prevalence"},{"id":"592dbfb6-31cc-55a6-a38e-b77abbd29565","slug":"prognosis","fullItemName":"Prognosis"},{"id":"f95b1f20-8f4d-5e8f-9e11-426b2a59246a","slug":"complications","fullItemName":"Complications"}]},{"id":"86e2bb04-52a3-5765-8605-aa439e65cf40","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"c3238d06-745f-57aa-b5f9-69dc42896f15","slug":"primary-angle-closure-glaucoma","fullItemName":"Primary angle closure glaucoma"},{"id":"f7c27cd1-50e2-5977-9f46-b1ae6e37f8c6","slug":"ocular-hypertension-primary-open-angle-glaucoma","fullItemName":"Ocular hypertension and primary open angle glaucoma"},{"id":"8f240bf4-5d3c-57ba-a2f7-5e0b82983e5c","slug":"opportunistic-testing-for-glaucoma","fullItemName":"Opportunistic testing for glaucoma"}]},{"id":"c621d247-f521-559a-93ce-c62c3ab5fd2b","fullItemName":"Management","slug":"management","subChapters":[{"id":"1e08cb89-b766-5a2f-9853-4406baa8635c","slug":"acute-angle-closure-angle-closure-glaucoma","fullItemName":"Scenario: Acute angle closure and angle closure glaucoma"},{"id":"803a56e6-2082-5ccc-add9-0d7bd9f32f6a","slug":"primary-open-angle-glaucoma-intraocular-hypertension","fullItemName":"Scenario: Primary open angle glaucoma and intraocular hypertension"}]},{"id":"2d512acb-6e34-566f-8f5f-90eb0d0c8431","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"d784c3ec-391a-5275-a286-56b128e61629","slug":"topical-prostaglandin-analogues-prostamides","fullItemName":"Topical prostaglandin analogues and prostamides"},{"id":"7d644d35-69fa-5a6f-8ceb-fab24019dcee","slug":"topical-beta-blockers","fullItemName":"Topical beta-blockers"},{"id":"7a8c1c4a-8a2d-5555-828d-58b50a740f88","slug":"topical-sympathomimetics","fullItemName":"Topical sympathomimetics"},{"id":"9a1dce0a-a42d-5d80-8ded-a8444facf830","slug":"carbonic-anhydrase-inhibitors","fullItemName":"Carbonic anhydrase inhibitors"},{"id":"efeb705d-eba6-581c-93ad-0916f0aed1c4","slug":"topical-miotics","fullItemName":"Topical miotics"}]},{"id":"657fc5fb-6ac1-5cfe-8fde-6a6eaf21e17b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"14521c62-39fa-5ea2-9b3b-ba4a79d55565","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"4d0bdf94-c9fe-564d-bd78-4e6e957019c7","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"4dec5995-8a6e-599f-a3ec-4401dda0f2fc","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"fbee715b-cedc-51e6-91f9-00319ab7944f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"802ad5b9-1cd1-59e9-8b22-2239d0b31c19","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4211d06e-9a65-51ea-ac4d-d35ca789f223","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"85b73253-be63-5a83-8948-152e3b5a51f7","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4665a282-8076-541c-8fdb-d884f514e73a","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"463829e7-8367-521e-b947-36b8a95680e1","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 4f9972ba-b6ce-41df-ab5b-0afaf5560ff9 --><h3>New evidence</h3><!-- end field 4f9972ba-b6ce-41df-ab5b-0afaf5560ff9 -->","summary":null,"htmlStringContent":"<!-- begin item 8012d311-9cbd-4d55-a003-67c51d4d6b66 --><!-- begin field a5d50d51-5c61-4073-ad09-8136f4338511 --><h3>Evidence-based guidelines</h3><!-- end field a5d50d51-5c61-4073-ad09-8136f4338511 --><!-- begin field 384cb16b-c859-433a-8baa-1899ed3f1598 --><p>No new evidence-based guidelines since 1 June 2020.</p><!-- end field 384cb16b-c859-433a-8baa-1899ed3f1598 --><!-- begin field b2004887-02d6-4a53-a597-280e1c7e77e4 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field b2004887-02d6-4a53-a597-280e1c7e77e4 --><!-- begin field 6b4dc69c-1b99-4b4b-b07c-eb2379c2b9ba --><p>No new HTAs since 1 June 2020.</p><!-- end field 6b4dc69c-1b99-4b4b-b07c-eb2379c2b9ba --><!-- begin field 8b11cb5e-45fe-44e0-990e-e39cb76a4d31 --><h3>Economic Appraisals</h3><!-- end field 8b11cb5e-45fe-44e0-990e-e39cb76a4d31 --><!-- begin field 0bb11de7-77c1-47a3-b810-0acc7d3a99ce --><p>No new economic appraisals relevant to England since 1 June 2020.</p><!-- end field 0bb11de7-77c1-47a3-b810-0acc7d3a99ce --><!-- begin field 5e6fdd65-362e-46b6-a23c-d065631ad51c --><h3>Systematic reviews and meta-analyses</h3><!-- end field 5e6fdd65-362e-46b6-a23c-d065631ad51c --><!-- begin field 6a1299df-56fd-4cfd-8ba2-8c502cd70a45 --><p>No new systematic reviews or meta-analyses since 1 June 2020.</p><!-- end field 6a1299df-56fd-4cfd-8ba2-8c502cd70a45 --><!-- begin field 353bef88-1d88-4746-adfc-10ee24988a45 --><h3>Primary evidence</h3><!-- end field 353bef88-1d88-4746-adfc-10ee24988a45 --><!-- begin field 1d6fdbd5-9560-4313-b294-85e83e20e943 --><p>No new randomized controlled trials published in the major journals since 1 June 2020.</p><!-- end field 1d6fdbd5-9560-4313-b294-85e83e20e943 --><!-- end item 8012d311-9cbd-4d55-a003-67c51d4d6b66 -->","subChapters":[]},{"id":"17de9be3-5337-5c30-8436-0c0a37cdd2e8","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field 509d60ab-518f-4353-a765-015b63fafcbe --><h3>New policies</h3><!-- end field 509d60ab-518f-4353-a765-015b63fafcbe -->","summary":null,"htmlStringContent":"<!-- begin item 0ae75309-ec69-4625-bb06-df7bacfbc914 --><!-- begin field ddeab9b4-caea-49f8-883e-335a975a2cfb --><p>No new national policies or guidelines since 1 June 2020.</p><!-- end field ddeab9b4-caea-49f8-883e-335a975a2cfb --><!-- end item 0ae75309-ec69-4625-bb06-df7bacfbc914 -->","subChapters":[]},{"id":"0db8f7d5-d0b1-500b-9af5-590589b48b76","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field edf964be-82d5-4289-9fe7-5f4af1b28147 --><h3>New safety alerts</h3><!-- end field edf964be-82d5-4289-9fe7-5f4af1b28147 -->","summary":null,"htmlStringContent":"<!-- begin item 07a0e5ae-a2c9-4883-b9a4-dc17fe90373f --><!-- begin field 42c5ee5e-94f7-4b73-aab5-6c967951b5ce --><p>No new safety alerts since 1 June 2020.</p><!-- end field 42c5ee5e-94f7-4b73-aab5-6c967951b5ce --><!-- end item 07a0e5ae-a2c9-4883-b9a4-dc17fe90373f -->","subChapters":[]},{"id":"a90ce9c8-84a1-5e88-b998-83cb908eea88","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field a84f62d5-c276-4439-93e6-27323c5e55b1 --><h3>Changes in product availability</h3><!-- end field a84f62d5-c276-4439-93e6-27323c5e55b1 -->","summary":null,"htmlStringContent":"<!-- begin item d10327e7-ac26-4d7f-9430-974b293675fa --><!-- begin field d7ec32b1-9497-44fc-bf37-5aae56a4f885 --><p>No changes in product availability since 1 June 2020.</p><!-- end field d7ec32b1-9497-44fc-bf37-5aae56a4f885 --><!-- end item d10327e7-ac26-4d7f-9430-974b293675fa -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}